BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12609840)

  • 21. Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia.
    Boas FE; Forman L; Beutler E
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3077-81. PubMed ID: 9501218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hydroxyurea on erythrocyte apoptosis in hemoglobinopathy patients.
    Kargutkar N; Nadkarni A
    Expert Rev Hematol; 2023; 16(9):685-692. PubMed ID: 37394969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A flow cytometry approach for quantitative analysis of cellular phosphatidylserine distribution and shedding.
    Freikman I; Amer J; Ringel I; Fibach E
    Anal Biochem; 2009 Oct; 393(1):111-6. PubMed ID: 19531362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reason sickle reticulocytes expose PS.
    Discher DE; Ney PA
    Blood; 2015 Oct; 126(15):1737-8. PubMed ID: 26450953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
    Bi SH; Cheng LT; Wang T
    Ren Fail; 2006; 28(7):573-6. PubMed ID: 17050240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins.
    Middelkoop E; Lubin BH; Bevers EM; Op den Kamp JA; Comfurius P; Chiu DT; Zwaal RF; van Deenen LL; Roelofsen B
    Biochim Biophys Acta; 1988 Jan; 937(2):281-8. PubMed ID: 3337804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume.
    Wandersee NJ; Punzalan RC; Rettig MP; Kennedy MD; Pajewski NM; Sabina RL; Paul Scott J; Low PS; Hillery CA
    Br J Haematol; 2005 Nov; 131(3):366-77. PubMed ID: 16225657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-oxidative band-3 clustering agents cause the externalization of phosphatidylserine on erythrocyte surfaces by a calcium-independent mechanism.
    Koshkaryev A; Livshits L; Pajic-Lijakovic I; Gural A; Barshtein G; Yedgar S
    Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183231. PubMed ID: 32119860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short survival of phosphatidylserine-exposing red blood cells in murine sickle cell anemia.
    de Jong K; Emerson RK; Butler J; Bastacky J; Mohandas N; Kuypers FA
    Blood; 2001 Sep; 98(5):1577-84. PubMed ID: 11520810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion.
    Setty BN; Kulkarni S; Stuart MJ
    Blood; 2002 Mar; 99(5):1564-71. PubMed ID: 11861269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin.
    Manodori AB; Barabino GA; Lubin BH; Kuypers FA
    Blood; 2000 Feb; 95(4):1293-300. PubMed ID: 10666202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P; Habibi A; Nzouakou R; Bachir D; Meunier-Costes N; Bonin P; Rodet M; Chami B; Galacteros F; Bierling P; Noizat-Pirenne F
    Transfusion; 2009 Sep; 49(9):1785-92. PubMed ID: 19413729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells.
    Haynes J; Obiako B; King JA; Hester RB; Ofori-Acquah S
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1679-85. PubMed ID: 16714363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulphydryl modifications alter scramblase activity in murine sickle cell disease.
    de Jong K; Kuypers FA
    Br J Haematol; 2006 May; 133(4):427-32. PubMed ID: 16643451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Band 3 and glycophorin are progressively aggregated in density-fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies.
    Corbett JD; Golan DE
    J Clin Invest; 1993 Jan; 91(1):208-17. PubMed ID: 8423219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of vitamin E and N-acetylcysteine on phosphatidylserine externalization and induction of coagulation by high-glucose-treated human erythrocytes.
    Jain SK; Palmer M; Chen Y
    Metabolism; 1999 Aug; 48(8):957-9. PubMed ID: 10459557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythrocyte phosphatidylserine exposure in β-thalassemia.
    Ibrahim HA; Fouda MI; Yahya RS; Abousamra NK; Abd Elazim RA
    Lab Hematol; 2014 Jun; 20(2):9-14. PubMed ID: 25000947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of F-reticulocytes in sickle cell disease.
    Horiuchi K; Osterhout ML; Ohene-Frempong K
    Biochem Biophys Res Commun; 1995 Dec; 217(3):924-30. PubMed ID: 8554617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.